More Medical News
Celgene approves buyback of up to $2.5 billion in stock
6/13/2012

(Reuters) - Celgene Corp said on Wednesday it authorized the supplementary


copyrights:cite this source roget's ii: the new lexicon



if (lexico_globals.googleafc.ads.content.length)
{
document.write(lexico_globals.googleafc.ads.contenttop);
document.write(lexico_globals.googleafc.ads.sponsoredlinks);
document.write(lexico_globals.googleafc.ads.content[2]);
document.write("") repurchase of up to $2.5 billion in common stock, productive immediately. In April, the biotechnology company said it repurchased about 2.35 million shares during the first qua...

More: - Continued here

Share |
(Posted in Medical School)
Share and enjoy
  • Digg
  • del.icio.us
  • DZone
  • Netvouz
  • NewsVine
  • Reddit
  • Slashdot
  • StumbleUpon
  • Technorati
  • YahooMyWeb
Entry 1 of 19080
Last Page | Next Page